Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that members of the management team are scheduled to p ...

B. Riley decreased their FY2027 earnings estimates for shares of Geron in a research note issued to investors on Tuesday, ...

B. Riley dropped their FY2025 earnings per share (EPS) estimates for shares of Geron in a research report issued to clients ...

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where ...

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday ...

Check a company’s competitiveness in the job market with alternative data that tracks hiring, job openings, and more.

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.